Theorem Clinical Research, Emergo Group Form Strategic Relationship
Theorem Clinical Research and Emergo Group have formed a strategic relationship to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community.
Theorem Clinical Research
and
Emergo Group
have formed a strategic relationship to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community.
“Emergo Group complements our own global
strategic regulatory affairs
and clinical trial capabilities,” said D. Lee Spurgin Jr., Ph.D., Theorem senior vice president and general manager of medical device and diagnostic development. “Working together we can provide more services and a bigger global footprint, so our strategic relationship helps us to be a one-stop provider for our clients.”
Emergo Group is a leading regulatory consultancy with more than 2,500 medical device and in vitro diagnostic device (IVD) clients and has offices offering a wide range of
compliance and market access services
in 25 countries. Emergo Group assists companies with global regulatory strategy, device registration, quality management system compliance, in-country regulatory representation and distributor qualification.
With offices in more than 30 countries worldwide, Theorem Clinical Research is a leading contract research organization specializing in the management of complex clinical trials for biopharmaceuticals, medical devices and drug-device combination products.
“The right strategic relationship strengthens both companies,” said Emergo Group President and CEO Rene van de Zande. “We believe the synergy we achieve with Theorem is a benefit to all concerned.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
